Addressing the issue, the Health chief stressed the importance of health education as a key component in combating the misuse of such treatments
Quick Answer: A microdose of GLP-1 is an informal term for using GLP-1 receptor agonist medications at doses substantially lower than those licensed by UK regulatory authorities, an approach that is not evidence-based or recommended
Xue XC, Wu YJ, Gao MT, Li WG, Zhao N, Wang ZL, et al
April 2025 A Maryland man filed a lawsuit against Novo Nordisk, claiming he developed non-arteritic anterior ischemic optic neuropathy (NAION) after taking Ozempic for diabetes
plantarum, can stimulate GLP-1 production
In the central nervous system, GLP-1s may impact neuronal function in conditions, such as Alzheimer's disease and Parkinson's disease, through multiple mechanisms